SCHEMBL17833287

SCHEMBL17833287

Cc1cccc2c(NCCCN)nc(-c3cc(-c4ccccc4Cl)cc(C(F)(F)F)c3)nc12

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SYK P43405 11/20 0.44
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP2D6 P10635 1/20 0.37
ROCK2 O75116 1/20 0.37
ROCK1 Q13464 1/20 0.37
MAPK1 P28482 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
SGK1 O00141 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.35
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
RAD52 P43351 1/20 0.34
KMT2A Q03164 1/20 0.34
STK17A Q9UEE5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829964 0.91 CYP1A2 (0.37) SYKCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL17829881 0.90 RAD52 (0.47) ALDH1A1MAPK1RAD52KMT2A
SCHEMBL17829952 0.88 SYK (0.49) SYKCYP1A2CYP3A4CYP2C19ALDH1A1
SCHEMBL17829946 0.84 SYK (0.47) SYKALDH1A1ROCK2ROCK1KDM4E
SCHEMBL17833268 0.84 SYK (0.56) SYKALDH1A1ROCK2ROCK1IRAK4
SCHEMBL17829578 0.82 RAD52 (0.47) ALDH1A1MAPK1RAD52KMT2A
SCHEMBL17833150 0.81 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19ALDH1A1CYP2D6
SCHEMBL17829956 0.80 SYK (0.47) SYKALDH1A1ROCK2ROCK1IRAK4
SCHEMBL17829874 0.80 RAD52 (0.47) CYP1A2CYP3A4CYP2C19ALDH1A1CYP2D6
SCHEMBL17833283 0.79 SYK (0.40) SYKCYP1A2CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016094730-A1 HETEROCYCLIC COMPOUNDS AS ANTIBIOTIC POTENTIATORS SYNERECA PHARMACEUTICALS, INC. (US) 2016-06-16 WO disclosed